The German Federal Patent Court has set aside a decision by the German Patent and Trade Mark Office (DPMA) to reject a supplementary protection certificate (SPC) that GSK Biologicals had applied for, in a decision of “fundamental importance”.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
German Federal Patent Court, German Patent and Trademark Office, patent, supplementary protection certificate, Hoffmann Eitle, Bianca-Lucia Vos, Klemens St